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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S167oxidant-induced mitochondrial dysfunction, OA relating catabolic
stress-induced caspase-9 activation and apoptosis in vitro. Furthermore,
Ogg1 silencing using siRNA reduced chondrocyte activity and augments
apoptosis in human chondrocytes. Treatment with C60 fullerene
induced the expression of Ogg1 and maintained its functions in
osteoarthritic chondrocytes even in the presence of OA relating catab-
olic factors.
Conclusion: Our recent study revealed the potential involvement of
accumulation of 8-Oxoguanine, an oxidized form of guanine, and
impairment of DNA repair enzyme Ogg1 in the pathogenesis of OA,
suggesting that Ogg1 prevents catabolic stress-mediated chondrocyte
dysfunction and apoptosis that might be important in the maintenance
of articular cartilage. C60 fullerene may have a therapeutic potential to
protect against the degeneration of articular cartilage through the
activation of Ogg1 in OA chondrocytes.
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CHONDROCYTE DEDIFFERENTIATION: ACTIN REGULATES THE
PASSAGED CELL PHENOTYPE THROUGH MRTFA
J. Parreno, S. Raju, A. Jiang, K. Andrejevic, R.A. Kandel. Lunenfeld-
Tanenbaum Res. Inst., Toronto, ON, Canada
Purpose: Articular cartilage when damaged is incapable of self-repair
and degeneration progresses to the point where joint replacement is
necessary. Autologous cell based repair of articular cartilage is a
promising therapy. While the US Food and Drug Administration has
approved the clinical use of chondrocytes that have been expanded in
vitro to obtain larger number of cells, cells cultured using traditional 2D
monolayer conditions undergo a phenotypic shift in a process termed
dedifferentiation. Passaged (dedifferentiated) cells are larger, spread
and acquire actin stress ﬁbers. They express ﬁbroblastic matrix (such as
type I collagen; COL1A1) as well as contractile (alpha smooth muscle
actin; aSMA) molecules resulting in biomechanically inferior tissue
capable of shrinkage. The study aim was to further characterize the
dedifferentiation process and gain insight into the molecular mecha-
nism regulating dedifferentiation. In particular, while actin depolyme-
rization has been shown to enhance the chondrogenic phenotype of
cells, the mechanisms downstream of actin leading to gene regulation
has not been fully elucidated. In other cell types actin depolymerization
has been shown to result in binding of myocardin related transcription
factor (MRTFa) to globular units of actin thereby removing MRTFa from
the nucleus where it acts as a coactivator of serum response factor (SRF).
Since MRTFa/SRF activation has been shown to regulate Col1A1 and
aSMA expression, and as these are expressed in passaged cells, we
hypothesized that passaged cells have a higher proportion of poly-
merized actin and nuclear MRTFa then primary chondrocytes. Actin
depolymerization or MRTFa/SRF inhibition should repress dediffer-
entiated molecule expression and promote a redifferentiated
phenotype.
Methods: Cell phenotype was initially characterized in terms of: mor-
phology through measurement of cell area and circularity; actin
organization through immunostaining with phalloidin-alexa 598 con-
jugate and assessment of globular-to-ﬁlamentous (g-/f-) actin ratio
through triton-solubility fraction separation followed by western blot;
MRTFa localization through immunocytochemistry and nuclear/cyto-
plasmic separation followed by western blot; expression of chondro-
genic, ﬁbroblastic, and contractile genes through real-time RT-PCR;
ﬁbroblastic and contractile molecule protein levels through western
blot analysis; and functional cell contraction assessment through
stress-relaxation of cell-embedded collagen gels.
Results: As compared to primary chondrocytes, passaged twice (P2)
cells were larger, less circular, developed actin stress ﬁbers, exhibited
lower g-/f-actin, and displayed a larger proportion of MRTFa within the
nucleus of cells (ﬁg.1). P2 cells had elevated expression levels of SRF-regulated ﬁbroblastic matrix and contractile molecules. Further, P2 cells
acquired the ability to contract stress-relaxed type I collagen gels.
Exposure of passaged cells to the actin depolymerization agent,
latrunculin B, resulted in decreased cell area, increased circularity, loss
of actin stress ﬁbers, increased g-/f-actin, higher cytoplasmic pro-
portion of MRTFa, repressed SRF-regulated gene expression, and
diminished ability to contract collagen gels. Cells exposed toMRTFa/SRF
inhibitor (CCG1423) still exhibited actin stress ﬁbers, however had
elevated g-/f-actin and cytoplasmic localization of MRTFa. Silencing of
MRTFa/SRF repressed speciﬁc dedifferentiated gene levels (ﬁg.2) as well
as decreased the ability of cells to contract collagen gels.
Conclusion: Actin polymerization activates the MRTFa/SRF pathway
and is responsible for the acquisition of the dedifferentiated phenotype
of passaged cells. Further, this study demonstrates that MRTFa/SRF
repression may be required in order to develop non-contractile, non-
ﬁbroblastic tissue by passaged cells. Understanding the process implicit
in dedifferentiation can facilitate development of methodology to
generate fully functional bioengineered articular cartilage tissue.
Figure 1. Confocal analysis of P0 and P2 cells þ/- drug treatment. MRTFa
(green) actin (phallodin; red) and nuclei (DAPI; blue). Scale bar 10mm
Figure 2. mRNA levels for (A) Col1a1 and (B) aSMA in P0 or P2 cells in the
presence or absence of the MRTF inhibitor, CCG14423. *p < 0.001 com-
pared to P2 control
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LONGITUDINAL ANALYSIS OF PRIMARY HUMAN ARTICULAR
CHONDROCYTE TRANSCRIPTOMIC REGULATION BY INTERLEUKIN
1b UNDER HYPEROSMOTIC CONDITIONS
S.R. Tew, B.T. McDermott, P.D. Clegg. Univ. of Liverpool, Liverpool, United
Kingdom
Purpose: The inﬂammatory cytokine interleukin-1b is known to induce
increased extracellular matrix turnover and reduced synthesis in
articular cartilage. Many studies have used this cytokine as an in vitro
model for cartilage turnover. On the whole, these investigations are
conducted using standard cell culture media with an osmolarity of
around 320mOsm. However the osmolarity that chondrocytes are
exposed to in vivo is generally much higher than this. This project
examines the how chondrocytes respond over a 24 hour period to
interleukin-1b stimulation and whether the osmotic environment
attenuates this response.
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lated by collagenase digestion from osteoarthritic tissue, plated at high
density and cultured for 5 days before being incubated in serum free
Dulbecco’s Modiﬁed Eagle Medium adjusted to 320mOsm or 450mOsm
with NaCl, for 24 hours. Interleukin 1b was then added to the cells and
RNA extracted at 0,1, 3, 6 and 24 hours. Transcript levels in the total RNA
were determined using Illumina HT12 microarrays. Array data was
merged and quantile normalised using the bioconductor beadarray
package in R for Mac v3.0.1. Data was then imported into multiple
experiment viewer v4.8.1 where data clustering and two-way analysis
of variance was performed.
Results: Interleukin 1b treatment led to early (within 1-3 hours) and
late (by 24 hours) gene responses. Hyperosmotic (450mOsm) con-
ditions caused altered response of a number of genes to interleukin 1b
stimulation. These included the RNA binding protein tristetraprolin, the
intermediate ﬁlament protein keratin 24 and the apoptosis mediator
PEG3. Tristetraprolin was of particular interest and was an early
response gene, being rapidly upregulated (at 1 hour) and then returning
quickly to baseline levels. Hyperosmotic conditions reduced the mag-
nitude of this induction by 2.4-fold.
Conclusions: This is the ﬁrst study to examine the longitudinal effect of
interleukin-1b in primary human chondrocytes at the whole tran-
scriptome level, where the interaction of osmotic environment with
cytokine stimulation has been taken into account. The nature of tran-
scripts that are rapidly induced by interleukin-1b are of interest as they
may represent pathways that are activated as part of limited cytokine
exposure during the maintenance of cartilage homeostasis in healthy
tissue. At present it is unclear how cytokine concentration and exposure
timemay further attenuate the regulation of these genes. Hyperosmotic
conditions, which are more representative of the in vivo chondrocyte
microenvironment, led to changes in interleukin 1b response in a sub
set of genes. One of these genes, tristetraprolin, is currently of interest to
us as a regulator of post-transcriptional gene expression in chon-
drocytes and its rapid induction by interleukin-1b may result in quick,
short term changes in the turnover of its target mRNAs.
279
NFAT1 DEFICIENCY CAUSES OSTEOARTHRITIS THROUGH
PATHOLOGICAL CHONDROCYTE DIFFERENTIATION IN ARTICULAR
AND PERIARTICULAR TISSUES
Q. Lu, J. Bernard, A. Miller, H. Anderson, J. Wang. Univ. of Kansas Med.
Ctr., Kansas City, KS, USA
Purpose: It has been recognized that hypertrophic differentiation of
articular chondrocytes may be involved in the pathogenesis of osteo-
arthritis (OA) and abnormal endochondral ossiﬁcation at the joint
margins causes osteophyte formation. However, the regulatory mecha-
nisms underlying pathological chondrocyte differentiation in the artic-
ular cartilage and periarticular tissues remain unclear. This study aimed
to investigate whether NFAT1, a member of the nuclear factor of acti-
vated T cells (NFAT) transcription factors, regulates chondrocyte differ-
entiation in articular cartilage and periarticular tissues in adult mice.
Methods: Nfat1 knockout (Nfat1-/-) mice were used in this study. Age-
matched wild-type (WT) mice were used as controls. All animal pro-
cedures were approved by the institutional animal care and use com-
mittee. Joint tissues with surrounding skeletal muscles were harvested
from hips, knees, and shoulders of Nfat1-/-andWTmice at 2, 3, 4, 6, and
12 months of age for histopathology, immunohistochemistry, and gene
expression analyses by quantitative real-time PCR (qPCR).
Results: At 2–6 months of age, focal loss of safranin-O stained proteo-
glycans was seen in the articular cartilage of Nfat1-/- mice. At 4-12
months of age, histological analyses demonstrated chondrocyte
hypertrophy in the deep-calciﬁed zones of Nfat1-/- articular cartilage,
which was conﬁrmed by immunohistochemistry showing up-regulated
expression of type-X collagen, a speciﬁc marker of hypertrophic chon-
drocytes. Pathological chondrocyte differentiation and endochondral
ossiﬁcationwere observed in the synovium as well as in the periosteum
and deep layer of skeletal muscles adjacent to the joint margins but not
in any other cartilage tissue (e.g., xiphoid) or non-skeletal tissues of
Nfat1-/- mice. The expression level of transforming growth factor
(TGF)-b1 and bone morphogenetic protein (BMP)-2, -13, and -14 was
signiﬁcantly increased in the periarticular tissues of Nfat1-/- mice
compared to WT mice. Osteoarthritic changes (e.g., chondrocyte clus-
tering in articular cartilage, articular surface ﬁbrillation, osteophyte
formation) were evident in Nfat1-/- mice at 12 months of age.Conclusions: NFAT1 suppresses hypertrophic differentiation of articu-
lar chondrocytes and chondrogenic differentiation of mesenchymal
progenitor cells in the periarticular tissues of adult mice. Therefore,
NFAT1 deﬁciency may cause osteoarthritis through pathological chon-
drocyte differentiation in articular cartilage and periarticular tissues.
NFAT1 deﬁciency may up-regulate the expression of BMP and TGF-b1 in
synovium and other periarticular tissues, which stimulates pathological
chondrocyte differentiation and endochondral ossiﬁcation in these
tissues.
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MAPPING NOVEL PROTEIN INTERACTIONS IN THE 3’UTR OF THE
MASTER CHONDROCYTE REGULATORY FACTOR SOX9
B.T. McDermott, P.D. Clegg, S.R. Tew. Univ. of Liverpool, Liverpool, United
Kingdom
Purpose: Degeneration of articular cartilage is a major problem to
our ageing population, causing pain and signiﬁcantly reduced
mobility. Disruption of the healthy chondrocyte phenotype is a
characteristic of age-related articular cartilage degeneration due to
an imbalance between cartilage extracellular matrix (ECM) synthesis
and turnover. The SOX9 transcription factor is a major regulator of
the chondrocyte phenotype and controls the expression of key car-
tilage ECM genes such as aggrecan and collagen II. Impaired SOX9
expression in humans and mice leads to inadequate chondrocyte
differentiation, with a modiﬁed cartilage ECM and SOX9 expression
is reduced during osteoarthritis. Recently, post-transcriptional regu-
lation of SOX9 has been demonstrated, mediated through the actions
of microRNAs. This project aims to understand how SOX9 can be
post-transcriptionally regulated through mechanisms mediated by
RNA binding proteins (RNABPs), which interact with elements within
the SOX9 3’UTR.
Methods: To assess the role of RNABPs in the post-transcriptional
regulation of SOX9 mRNA, an siRNA approach was used to knockdown
the expression of three RNABPs (TTP, KSRP and HuR) in both a human
chondrosarcoma cell line (SW1353) and in human articular chon-
drocytes (HACs). Expression of key ECM genes was then analysed by
real time PCR and normalised to the GAPDH housekeeping gene. The
signiﬁcance of the differences in gene expressionwas determined using
repeated measures ANOVA and paired student’s t-test in SPSS. P < 0.05
was deemed signiﬁcant.
To identify which regions of the SOX9 3’UTR are responsible for
allowing SOX9 to be post-transcriptionally controlled, biotinylated RNA
probes that represent the eight AU-rich sites within the SOX9 3’UTR
were produced. These RNA probes were employed in electromobility
shift assays (EMSAs) using HAC cell lysates to identify interactions
between the SOX9 3’UTR and chondrocyte proteins. HAC lysates were
obtained from HACs cultured in normal (330 mOsm) and hyperosmotic
(450 mOsm) conditions, under 21% and 5% oxygen.
Results: We have shown that in both SW1353s and HACs, treatment
with RNABP siRNAs gave signiﬁcantly reduced RNABP expression.
However, there was reduced knockdown of KSRP and HuR expression
when TTP was also knocked down, suggesting that TTP is a negative
regulator of KSRP and HuR. Knockdown of TTP led to increases in the
expression of SOX9, aggrecan and collagen II mRNAs. We found
increased SOX9, aggrecan and collagen II expression when TTP was
knocked down alone and when knocked down in combination with
KSRP and HuR. Knockdown of TTP and SOX9 simultaneously by siRNA
did not reduce aggrecan mRNA induction in SW1353 cells, suggesting
that the effect of TTP is not SOX9-dependent. Results from EMSAs have
shown that six of the eight SOX9 3’UTR AU-rich elements interact with
chondrocyte proteins from two separate HAC donors and one of the
binding sites appears to show altered interactions under different
physiological stimuli.
Conclusions: Knocking down the expression of RNABPs that target the
SOX9 3’UTR have been shown to increase the expression of cartilage
ECM genes and also reveal a degree of cross-talk between TTP and the
other RNABPs examined. EMSA analysis demonstrates that chondrocyte
proteins bind to six of the eight AU-rich elements present in the SOX9
3’UTR. There is evidence that at least one of these sites acts as an
osmotic/hypoxic response element. Further work is underway to
determine whether similar interacts occur in the aggrecan 3’UTR and to
conﬁrmwhether aggrecan regulation by TTP occurs as a consequence of
altered SOX9 expression. This work is kindly funded by the Biological
and Biotechnological Sciences Research Council.
